02.08.2018
- Agrochemical and biotech companies based in the EU are assessing a ruling last week by the European Court of Justice (ECJ) that could potentially make work with genetically edited...
29.07.2018
- Eli Lilly has announced plans to spin off its Elanco animal health business, ending months of uncertainty. The US drugmaker said it will file a registration in the coming weeks...
04.07.2018
- US pharma Catalent has agreed to buy Juniper Pharmaceuticals, including UK-based Juniper Pharma Services, for $133 million, boosting its drug development activities. The addition...
25.06.2018
- Danish drugmaker Novo Nordisk is collaborating with Kallyope, a US biotech focused on the gut-brain axis, to discover novel peptide therapeutics for obesity and diabetes. Kallyope...
18.06.2018
- The US Food and Drug Administration (FDA) has granted two more approvals for US Merck’s Keytruda, an anti-PD-1 therapy. In the first, the drug gained its first regulatory clearance...
14.06.2018
- BASF Venture Capital, the subsidiary of the Ludwigshafen chemical giant that takes stakes in start-ups, is investing an undisclosed sum in LanzaTech, a US biotech firm...
08.06.2018
- Bayer’s pharmaceutical division has signed a five-year collaboration agreement to work with the MD Anderson Cancer Center at the University of Texas in an effort to accelerate the...
07.06.2018
- German pharmaceuticals and chemicals life sciences group Merck KGaA has opened a BioReliance End-to-End Biodevelopment Center in Burlington, Massachusetts. The center is one of...
05.06.2018
- The digital developments in the healthcare industry, combined with an aging population and enormous scientific progress, pose new challenges for pharmaceutical companies. On the...
30.05.2018
- Sandoz, part of Swiss drugmaker Novartis, has won approval from the European Commission for its biosimilar Zessly (infliximab). The drug, which is a version of Janssen Biotech’s...
